IRIS
IMBERTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.325
NA - Nord America 999
EU - Europa 367
SA - Sud America 207
AF - Africa 51
OC - Oceania 2
Totale 2.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 941
SG - Singapore 483
BD - Bangladesh 294
VN - Vietnam 254
IT - Italia 171
BR - Brasile 130
FR - Francia 110
CN - Cina 88
IN - India 42
HK - Hong Kong 34
AR - Argentina 25
IQ - Iraq 22
ZA - Sudafrica 20
CA - Canada 18
GB - Regno Unito 16
PH - Filippine 14
EC - Ecuador 13
MX - Messico 13
ID - Indonesia 12
TR - Turchia 12
IE - Irlanda 11
VE - Venezuela 11
CO - Colombia 10
PK - Pakistan 10
RU - Federazione Russa 10
DE - Germania 9
MA - Marocco 9
SA - Arabia Saudita 9
CL - Cile 8
NL - Olanda 8
ES - Italia 7
JM - Giamaica 7
MY - Malesia 7
PL - Polonia 7
UZ - Uzbekistan 6
EG - Egitto 5
JP - Giappone 5
KE - Kenya 5
AT - Austria 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
JO - Giordania 4
PY - Paraguay 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
NI - Nicaragua 3
NP - Nepal 3
PS - Palestinian Territory 3
HN - Honduras 2
IL - Israele 2
LT - Lituania 2
LU - Lussemburgo 2
OM - Oman 2
SE - Svezia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UA - Ucraina 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 2.951
Salva come PNG Salva come JPEG
Città #
San Jose 381
Singapore 186
Lauterbourg 104
Ashburn 89
Ho Chi Minh City 85
Boardman 73
Hanoi 65
New York 60
Los Angeles 53
Buffalo 48
Hong Kong 27
Rome 24
Santa Clara 19
Baghdad 12
Dallas 12
Milan 12
Dublin 11
Naples 10
Johannesburg 9
Orem 9
Turin 9
Bologna 7
Charlotte 7
Caracas 6
Guayaquil 6
Haiphong 6
São Paulo 6
Warsaw 6
Catania 5
Da Nang 5
Durban 5
Karbala 5
Kingston 5
Nuremberg 5
Tashkent 5
Baku 4
Bari 4
Biên Hòa 4
Cairo 4
Casablanca 4
Chicago 4
Denver 4
Lahore 4
Manchester 4
Manila 4
Medellín 4
Palermo 4
Quito 4
Rio de Janeiro 4
Toronto 4
Tây Ninh 4
Atlanta 3
Brasília 3
Brooklyn 3
Fortaleza 3
Guangzhou 3
Guatemala City 3
Houston 3
Hyderabad 3
Hải Dương 3
Istanbul 3
Jaipur 3
Jeddah 3
Jinan 3
Kenitra 3
Managua 3
Mexicali 3
Mexico City 3
Mumbai 3
Nairobi 3
Pasadena 3
Passo Fundo 3
Riyadh 3
Salvador 3
San Francisco 3
Santiago 3
Taranto 3
Thái Bình 3
Tokyo 3
Verona 3
Vĩnh Long 3
Adana 2
Addis Ababa 2
Ambato 2
Amman 2
Amsterdam 2
Ankara 2
Asunción 2
Beijing 2
Belo Horizonte 2
Boston 2
Buenos Aires 2
Bến Tre 2
Cagliari 2
Can Tho 2
Chandigarh 2
Chengdu 2
Chennai 2
Curitiba 2
Dammam 2
Totale 1.569
Salva come PNG Salva come JPEG
Nome #
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 103
Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 80
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 62
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 61
"Timing" of arrival and in-hospital mortality in a cohort of patients under anticoagulant therapy presenting to the emergency departments with cerebral hemorrhage: A multicenter chronobiological study in Italy 58
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 54
Low-Molecular-Weight Heparins: Before or After Surgery? New Concepts and Evidence Congress Report from the SIGMA TAU/ROVI Satellite Symposium (Rome, Italy, 13 November 2006) 51
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 50
An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study 49
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery 44
Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature 42
Factors associated with the timing of diagnosis of venous thromboembolism: Results from the MASTER registry 42
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 39
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients 39
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry 39
D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism 38
Extended oral anticoagulant therapy after a first episode of pulmonary embolism 37
A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum) 37
Management Strategies for Vitamin K Antagonists Reversal in Patients With Major Bleeding: A Survey of Italian Emergency Departments 37
Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain 36
Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage 35
Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia 35
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 33
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms 33
Successful Protein C Concentrate Administration during Initiation of Oral Anticoagulation in Adult Patients with Severe Congenital Protein C Deficiency: Report of Two Cases 32
The safety and efficacy of full-versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial 32
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry 32
Higher mortality rate in patients hospitalised for acute pulmonary embolism during weekends 32
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 31
A survey of thromboprophylaxis management in patients with major trauma 30
Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study 30
Clinical management of rivaroxaban-treated patients 29
Serial 2-point ultrasonography plus D-Dimer vs whole-leg color-coded doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis - A randomized controlled trial 28
Retrievable vena cava filters: a review 27
Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review 27
Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage 27
A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism 27
A survey of thrombosis prophylaxis use in patients with lower limb fractures 27
Epidemiology and risk factors of venous thromboembolism 27
Seasonal and Weekly Patterns of Occurrence of Acute Cardiovascular Diseases: Does a Gender Difference Exist? 27
Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 26
Venous thromboembolism after major orthopaedic surgery: a population-based cohort study 26
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding 26
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 26
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry 26
A commentary: To screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry 26
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy 26
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients 25
Prophylaxis of Venous Thromboembolism with Low Molecular Weight Heparin in Bariatric Surgery: a Prospective, Randomised Pilot Study Evaluating Two Doses of Parnaparin (BAFLUX Study) 25
Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery 25
Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update 24
Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum) 24
Higher mortality in patients hospitalized for acute aortic rupture or dissection during weekends 24
Inferior vena cava filters: use or abuse? 24
Prophylaxis of venous thromboembolism in bariatric surgery: A prospective randomized study comparing two doses of parnaparin 24
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY) 24
Retrievable vena cava filters: clinical experience 23
Retrievable vena cava filters: a clinical review 23
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis 23
Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review 22
The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry 22
EXTENDED PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS UNDERGOING MAJOR ORTHOPAEDIC SURGERY IN ITALY: A PHARMACOECONOMIC STUDY 22
Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban 21
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment 21
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 21
SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature 21
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry 21
Management of primary care patients with suspected deep vein thrombosis use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation 20
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study 20
Interventional Approaches in VTE Treatment (Vena Cava Filters, Catheter-Guided Thrombolysis, Thrombosuction) 20
Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism 20
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists A meta-analysis 19
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 19
The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2 19
Effectiveness of recombinant factor VIIa in haemorragic cancer-related disseminated intravascular coagulation: a case report 18
Venous thromboembolism prophylaxis in medical patients: Future perspectives 18
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study 18
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 18
Venous thromboembolism in patients undergoing shoulder surgery: findings from the Recos registry 17
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury A prospective cohort study 17
Interventional treatment of venous thromboembolism: A review 17
Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope 17
Prognostic relevance of asymptomatic venous thromboembolism in patients with cancer 17
Retrievable vena cava filters: Key considerations 17
Practical Management of Rivaroxaban for the Treatment of Venous Thromboembolism 16
Primary prophylaxis of VTE in cancer outpatients 16
Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution 16
The Optimal Duration of Anticoagulant Therapy In patients with Cancer-Related Deep Vein Thrombosis: The Advantage of Using Residual Vein Thrombosis (the Cancer-DACUS Study) 16
Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 16
Venous thromboembolism in patients undergoing shoulder surgery: Findings from the RECOS Registry 16
I Study EINSTEIN CHOICE 16
The MASTER registry on venous thromboembolism: Description of the study cohort 15
HIGH PREVALENCE OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR SYNCOPE 15
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) 15
Low Molecular Weight Heparins and Glomerular Filtration Rate: A Report to be Considered 15
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill 15
The practical management of NAO 15
Venous Thromboembolism Prevention in Patients with Heart Failure: An Often Neglected Issue 15
Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry 15
Long term clinical outcomes of cancer associated venous thromboembolism: findings from the MASTER registry 14
Totale 2.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 3 0 0 0 0 1 1 0
2024/202583 0 3 24 0 6 6 3 1 8 8 4 20
2025/20262.987 12 22 27 251 349 252 323 107 656 267 424 297
Totale 3.075